Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (6): 1074-1081. doi: 10.19723/j.issn.1671-167X.2023.06.019

Previous Articles     Next Articles

Epidemiology and hospitalization costs analysis of female inpatients with acute exacerbation of chronic obstructive pulmonary disease in Beijing from 2013 to 2020

Zi-kai WANG1,Jia-li MO2,Meng ZHANG1,Ji-ping LIAO1,*()   

  1. 1. Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China
    2. Departmant of Pediatrics, Peking University First Hospital, Beijing, 100034, China
  • Received:2023-07-11 Online:2023-12-18 Published:2023-12-11
  • Contact: Ji-ping LIAO E-mail:jipingliao@hotmail.com
  • Supported by:
    Beijing Health Technologies Promotion Program(BHTPP202053);Beijing Municipal Commission of Science and Technology(Z221100007422040)

Abstract:

Objective: To study epidemiological characteristics and hospitalization costs of female inpatients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Beijing. Methods: A retrospective study was conducted to analyze electronic hospitalization summary reports of female inpatients with AECOPD in Beijing from 2013 to 2020. Clinical characteristics (age distribution and comorbidities), epidemiological characteristics (temporal and spatial distribution characteristics), hospi-talization times and costs of patients were described. Results: A total of 57 911 subjects in 166 hospitals were included in this study, with a mean age of (78.84±8.59) years and the highest number of patients aged 80-89 years (49.06%), followed by patients aged 70-79 years (31.08%), and the lowest number of patients under 50 years (0.41%). The proportions of patients with coronary heart disease, hypertension and heart failure were 30.60%, 30.52% and 26.54% respectively. The median number of daily hospitalizations during the study period was 18 (IQR: 16). The number of daily hospitalizations for AECOPD showed an overall growth trend over the eight years from 2013 to 2020, starting to increase significantly in 2015 and continuing to increase until 2019, then followed by a decline in 2020. The proportion of inpatient admissions was higher in winter and spring (54.09%) than that in summer and autumn (45.91%). The top three districts in terms of the proportion of total inpatient admissions were Xicheng district (14.18%), Chaoyang district (14.12%) and Fengtai district (13.47%). The density of inpatients was relatively high in the western regions, central urban areas and northeastern regions of the city, while the density of inpatients was relatively low in the near suburbs. The median number of hospital days for female patients with AECOPD was 12 days, and the median hospital costs was CNY 20 648.37. Patients from urban areas had longer hospitalization times and higher hospitalization costs than those from suburban areas (P < 0.001). Western medicine expenses accounted for the largest proportion of total hospital expenses (33.32%). During the study period, hospitalization costs exhibited an overall pattern of initial growth, followed by subsequent decline, eventually stabilizing. The differences in hospitalization costs among the patients with different comorbidities were significant. Conclusion: Female hospitalized patients with AECOPD in Beijing were older than 70 years, often complicated by cardiovascular disease. AECOPD occurred mainly in winter and spring, with regional differences. The hospitalization costs were closely associated with the patients' age, comorbidities, and the geographicical region.

Key words: Acute exacerbation of chronic obstructive pulmonary disease, Female, Hospitalization costs, Epidemiology

CLC Number: 

  • R563.9

Table 1

Clinical characteristics of total and daily hospital admissions of female patients with AECOPD in Beijing from 2013 to 2020"

Items n (%) Characteristics of daily hospital admissions
M Min Max IQR
Total 57 911(100.00) 18 1 174 16
Age/years
  18-49 237 (0.41) 1 1 3 0
  50-59 1 786 (3.08) 1 1 8 1
  60-69 5 905 (10.20) 2 1 22 2
  70-79 17 996 (31.08) 6 1 56 5
  80-89 28 413 (49.06) 9 1 75 9
  ≥90 3 574 (6.17) 2 1 12 1
Complications
  Coronary heart disease 17 723 (30.60) 6 1 56 6
  Atrial fibrillation 3 473 (6.00) 1 1 10 1
  Heart failure 15 370 (26.54) 5 1 44 5
  Hypertension 17 675 (30.52) 6 1 47 6
  Diabetes 6 643 (11.47) 2 1 16 3

Figure 1

Time series chart of daily hospital admissions of female patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Beijing from 2013 to 2020"

Table 2

Seasonal variations of total and daily hospital admissions of female patients with AECOPD in Beijing from 2013 to 2020"

Items n (%) Characteristics of daily hospital admissions
M Min Max IQR
Spring 14 312 (24.71) 17 1 56 16
Summer 12 501 (21.59) 16 1 43 13
Autumn 14 083 (24.32) 17 1 58 16
Winter 17 015 (29.38) 22 1 174 20

Table 3

Spatial distribution of total and daily hospital admissions of female patients with AECOPD in Beijing from 2013 to 2020"

Items n (%) Characteristics of daily hospital admissions
M Min Max IQR
Urban areas
  Dongcheng 6 643 (11.47) 3 1 14 2
  Xicheng 8 212 (14.18) 3 1 13 3
  Chaoyang 8 175 (14.12) 3 1 14 2
  Haidian 5 705 (9.85) 2 1 12 2
  Fengtai 7 800 (13.47) 3 1 14 2
  Shijingshan 4 560 (7.87) 2 1 12 2
Suburban areas
  Daxing 2 060 (3.56) 1 1 22 1
  Tongzhou 1 092 (1.89) 1 1 5 0
  Shunyi 1 288 (2.22) 1 1 11 1
  Changping 1 800 (3.11) 1 1 8 1
  Mentougou 2 449 (4.23) 1 1 10 1
  Fangshan 4 244 (7.33) 2 1 33 2
  Huairou 735 (1.27) 1 1 7 0
  Pinggu 865 (1.49) 1 1 5 0
  Miyun 1 010 (1.74) 1 1 6 1
  Yanqing 1 273 (2.20) 1 1 15 1

Figure 2

Spatial distribution chart of hospitalizations density of female patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Beijing from 2013 to 2020 (/10 000 person-years)"

Table 4

Hospitalization times and costs of female patients with AECOPD in Beijing from 2013 to 2020"

Items Hospitalization times /d, M (IQR) H/U P value Hospitalization costs /yuan, M (IQR) H/U P value
Total 12 (8) 20 648.37 (17 357.88)
Age/years 459.92 <0.001 1 495.66 <0.001
  18-49 9 (6) 13 494.52 (9 356.01)
  50-59 11 (6) 15 707.68 (11 404.33)
  60-69 13 (9) 17 048.92 (12 861.81)
  70-79 13 (6) 20 197.73 (16 160.18)
  80-89 14 (8) 22 173.09 (18 848.26)
  ≥90 12 (7) 21 754.29 (18 915.54)
With complications 99.46 <0.001 489.08 <0.001
  Yes 11 (7) 20 118.93 (15 629.94)
  No 12 (9) 21 457.84 (19 992.87)
Season 27.07 <0.001 6.78 0.079
  Spring 12 (8) 20 641.66 (16 961.2)
  Summer 12 (8) 20 903.46 (17 822.19)
  Autumn 12 (8) 20 503.37 (16 828.64)
  Winter 11 (8) 20 631.11 (17 683.63)
Areas 1 590.98 <0.001 4 358.15 <0.001
  Urban areas 13 (8) 22 843.59 (18 307.91)
  Suburban areas 10 (7) 15 159.72 (11 985.30)

Figure 3

Composition ratio of hospitalization costs of female patients with AECOPD in Beijing from 2013 to 2020"

Figure 4

Time distribution of hospitalization costs of female patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and different comorbidities in Beijing from 2013 to 2020"

1 Yin P , Wu J , Wang L , et al. The burden of COPD in China and its provinces: Findings from the global burden of disease study 2019[J]. Front Public Health, 2022, 10, 859499.
doi: 10.3389/fpubh.2022.859499
2 Cao Y , Xing Z , Long H , et al. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit[J]. Respir Res, 2021, 22 (1): 77.
doi: 10.1186/s12931-021-01657-4
3 Prediletto I , Giancotti G , Nava S . COPD exacerbation: Why it is important to avoid ICU admission[J]. J Clin Med, 2023, 12 (10): 3369.
doi: 10.3390/jcm12103369
4 Warwick M , Fernando SM , Aaron SD , et al. Outcomes and resource utilization among patients admitted to the intensive care unit following acute exacerbation of chronic obstructive pulmonary disease[J]. J Intensive Care Med, 2021, 36 (9): 1091- 1097.
doi: 10.1177/0885066620944865
5 Celli BR , Fabbri LM , Aaron SD , et al. Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: Best practice[J]. Am J Respir Crit Care Med, 2023, 207 (9): 1134- 1144.
doi: 10.1164/rccm.202209-1795CI
6 Wu Y , Wang Z , Zheng Y , et al. Trends in Hospital admissions for chronic obstructive pulmonary diseases after comprehensive tobacco control policies in Beijing, China[J]. Nicotine Tob Res, 2022, 24 (12): 1978- 1984.
doi: 10.1093/ntr/ntac137
7 Scicluna V , Han M . COPD in women: future challenges[J]. Arch Bronconeumol, 2023, 59 (1): 3- 4.
doi: 10.1016/j.arbres.2022.06.008
8 Gao N , Li C , Ji J , et al. Short-term effects of ambient air pollution on chronic obstructive pulmonary disease admissions in Beijing, China (2013-2017)[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14, 297- 309.
doi: 10.2147/COPD.S188900
9 Zysman M , Raherison-Semjen C . Women's COPD[J]. Front Med, 2021, 8, 600107.
10 Han MK , Postma D , Mannino DM , et al. Gender and chronic obstructive pulmonary disease: Why it matters[J]. Am J Respir Crit Care Med, 2007, 176 (12): 1179- 1184.
doi: 10.1164/rccm.200704-553CC
11 Bhatt SP , Bodduluri S , Nakhmani A , et al. Sex differences in airways at chest CT: Results from the COPD gene cohort[J]. Radiology, 2022, 305 (3): 699- 708.
doi: 10.1148/radiol.212985
12 Cheng LL , Liu YY , Su ZQ , et al. Clinical characteristics of tobacco smoke-induced versus biomass fuel-induced chronic obstructive pulmonary disease[J]. J Transl Int Med, 2015, 3 (3): 126- 129.
doi: 10.1515/jtim-2015-0012
13 Kamal R , Srivastava AK , Kesavachandran CN , et al. Chronic obstructive pulmonary disease (COPD) in women due to indoor biomass burning: A meta analysis[J]. Int J Environ Health Res, 2022, 32 (6): 1403- 1417.
doi: 10.1080/09603123.2021.1887460
14 Xu M , Ke P , Wang C , et al. Cooking with biomass fuels and mortality among Chinese elderly people: A prospective cohort study[J]. Indoor Air, 2022, 32 (1): e12954.
15 Macdonald MI , Shafuddin E , King PT , et al. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease[J]. Lancet Respir Med, 2016, 4 (2): 138- 148.
doi: 10.1016/S2213-2600(15)00509-3
16 Wang C , Xu J , Yang L , et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health[CPH] study): A national cross-sectional study[J]. Lancet, 2018, 391 (10131): 1706- 1717.
doi: 10.1016/S0140-6736(18)30841-9
17 Rogliani P , Lauro D , Di Daniele N , et al. Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: A benefit of inhaled corticosteroids[J]. Expert Rev Respir Med, 2021, 15 (4): 561- 568.
doi: 10.1080/17476348.2021.1850275
18 Wang Z , Zhou Y , Luo M , et al. Association of diurnal temperature range with daily hospitalization for exacerbation of chronic respiratory diseases in 21 cities, China[J]. Respir Res, 2020, 21 (1): 251.
doi: 10.1186/s12931-020-01517-7
19 Radicioni G , Ceppe A , Ford AA , et al. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort[J]. Lancet Respir Med, 2021, 9 (11): 1241- 1254.
doi: 10.1016/S2213-2600(21)00079-5
20 Li M , Chen S , Zhao H , et al. The short-term associations of chronic obstructive pulmonary disease hospitalizations with meteorological factors and air pollutants in Southwest China: A time-series study[J]. Sci Rep, 2021, 11 (1): 12914.
doi: 10.1038/s41598-021-92380-z
21 Liu Y, Han X, Cui X, et al. Association between air pollutants and acute exacerbation of chronic obstructive pulmonary disease: A time stratified case-crossover design with a distributed lag nonlinear model[J]. Geohealth, 2022, 6(2): e2021GH000529.
22 Zhang L , Zhao N , Zhang W , et al. Changes in long-term PM2.5 pollution in the urban and suburban areas of China's three largest urban agglomerations from 2000 to 2020[J]. Remote Sensing, 2022, 14 (7): 1716.
doi: 10.3390/rs14071716
23 Jiang X , Xiao H , Segal R , et al. Trends in readmission rates, hospital charges, and mortality for patients with chronic obstructive pulmonary disease (COPD) in Florida from 2009 to 2014[J]. Clin Ther, 2018, 40 (4): 613 e1- 626 e1.
24 Kim J , Lee TJ , Kim S , et al. The economic burden of chronic obstructive pulmonary disease from 2004 to 2013[J]. J Med Econ, 2016, 19 (2): 103- 110.
25 Chen YH , Yao WZ , Cai BQ , et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Chin Med J (Engl), 2008, 121 (7): 587- 591.
doi: 10.1097/00029330-200804010-00003
26 Schermer TR , Hendriks AJ , Chavannes NH , et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice[J]. Prim Care Respir J, 2004, 13 (1): 48- 55.
doi: 10.1016/j.pcrj.2003.11.005
[1] Zhe WANG,Wei SUN,Xue YANG,Ying SONG,Ai-ping JI,Jie BAI. Clinical analysis of patients with oral and maxillofacial infections in oral emergency [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 543-547.
[2] Xue-zhao JI,Shan LIU,Wan-zhou WANG,Ye-tong ZHAO,Lu-yi LI,Wen-lou ZHANG,Guo-feng SHEN,Fu-rong DENG,Xin-biao GUO. Associations between indoor volatile organic compounds and nocturnal heart rate variability of young female adults: A panel study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 488-494.
[3] Xi-ya SUN,Yi-lu CHEN,Lin ZENG,Li-ying YAN,Jie QIAO,Rong LI,Xu ZHI. Correlation analysis of vitamin D level and anti-Müllerian hormone in infertile female and the role in predicting pregnancy outcome [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 167-173.
[4] Si-wei DENG,Ze-yi CHEN,Zhi-ke LIU,Jian WANG,Lin ZHUO,Shuang-qing GAO,Jia-kuo YU,Si-yan ZHAN. Epidemiological study of bone and joint injury based on urban medical insurance database [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 527-534.
[5] Li-jun ZHAO,Hong-tian LI,Ya-li ZHANG,Yu-bo ZHOU,Jian-meng LIU. Mobile terminal-based survey on the birth characteristics for Chinese newborns [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 813-818.
[6] Wei-yu ZHANG,Qiu-xiang XIA,Hao HU,Jing-wen CHEN,Yi-ran SUN,Ke-xin XU,Xiao-peng ZHANG. Analysis of urodynamic study of female outpatients with lower urinary tract symptoms and follow-up of the patients with detrusor underactive [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 856-862.
[7] Xin-yan CHE,Shi-liang WU,Yu-ke CHEN,Yan-bo HUANG,Yang YANG. A survey of risk factors and quality of life in female medical staff with urinary incontinence [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 706-710.
[8] WANG Dan-dan, GAN Ye-hua, MA Xu-chen, MENG Juan-hong. Association between ADAMTS14 gene polymorphism and the temporomandibular joint osteoarthritis in Chinese Han females [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 279-283.
[9] ZHANG Wei-yu, ZHANG Xiao-peng, CHEN Jing-wen, SUN Yi-ran, WANG Jia, HU Hao, XU Ke-xin. Effect of age on urodynamic parameters of women with urinary incontinence [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 825-829.
[10] ZHOU Yu-Bo, LUO Shu-Sheng, LI Hong-Tian, GAO Yan-Qiu, LIU Jian-Meng. Secular trends of premarital medical examination in China during 1996 and 2013 [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 437-442.
[11] JIA Xiao-Jun, FANG Zhi-Wei, HU Hao, XU Ke-Xin, HUANG Xiao-Bo, WANG Xiao-Feng. Influence of tension-free midurethral sling surgery on sexual function in women with stress urinary incontinence [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 570-573.
[12] HUANG Guang-Lin, MAN Li-Bo, WANG Hai, WANG Jian-Wei, DI Jian-Po, ZHU Xiao-Fei, ZHOU Ning, XU Xiao. Management of female urethral obliteration with the rotary excision appliance [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 574-577.
[13] DENG Qiu-ju, PAN Ya-qi, WANG Chao-yi, LI Feng-lei, LV Shao-jiang, HU Shao-yong, NING Tao, GUO Chuan-hai, HE Zhong-hu, KE Yang. Prevalence and risk factors for hepatitis B in Hua County, Henan Province [J]. Journal of Peking University(Health Sciences), 2013, 45(6): 965-970.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!